See every side of every news story
Get Started
SubscribeLogin
onclive.com image

News from onclive.com

Top onclive.com News

The OncFive: Top Oncology Articles for the Week of 5/11
Cancer

The OncFive: Top Oncology Articles for the Week of 5/11

The FDA has approved options in non–small cell lung cancer, advanced anal cancer, and pheochromocytoma or paraganglioma, and more from OncLive this week.See the Story
Cemiplimab Displays Survival Benefits Over Chemotherapy in First-Line Advanced PD-L1–High NSCLC With Brain Metastases

Cemiplimab Displays Survival Benefits Over Chemotherapy in First-Line Advanced PD-L1–High NSCLC With Brain Metastases

First-line cemiplimab extended median PFS and OS vs chemotherapy in patients with untreated advanced NSCLC with brain metastases.Read Article
Dr Vlachou on the Rationale for Evaluating Perioperative Enfortumab Vedotin Plus Pembrolizumab in Upper Tract Urothelial CancerCancer
Maryland · Maryland

Dr Vlachou on the Rationale for Evaluating Perioperative Enfortumab Vedotin Plus Pembrolizumab in Upper Tract Urothelial CancerCancer

Evangelia Vlachou, MD, discusses the investigation of enfortumab vedotin plus pembrolizumab as perioperative therapy in upper tract urothelial cancer.Read Article

Breaking News Topics Related to onclive.com

Maryland icon

Maryland

Breast Cancer icon

Breast Cancer

Cancer icon

Cancer

United States icon

United States

News
For You
SearchBlindspotLocal